2016
2016-03 Company established
2017
2017 Research and Production Center for Cell Therapy Products established in Shanghai Thousand Talents Plan Entrepreneurship Park
2019
2019-03 ISO9001:2015 Quality Management System certified
2020
2020-06 Inspection Report obtained from National Institute for Food and Drug Control (China)
2021
2021-10 Kick off meeting of clinical research project with Sichuan Provincial People's Hospital (Liver cirrhosis)
2021-12 Intellectual Property Management System certified
2022
2022-05 1st IND approval (Indication: Acute Respiratory Distress Syndrome, ARDS)
2022-05 2nd IND approval (Indication: Ankylosing Spondylitis, AS)
2022-09 3rd IND approval (Indication: Burn)
2022-12 4th IND approval (Indication: Liver Cirrhosis)
2023
2023-04 1st ARDS patient enrolled
2023-06 4000m² pilot plant completed in Shanghai
2023-04 1st liver cirrhosis patient enrolled
2023-12 All ankylosing spondylitis patients enrolled in Phase I clinical trial